The Cell Surgical Network is proud to have published one of the largest safety data paper on the use of autologous stromal vascular fraction (SVF) to date, including intravenous infusions. This paper comes from the work of many of our founding members, their dedication to our institutional review board approved processes, and their work in tracking patient outcomes through our network wide database. While the Cell Surgical Network aims to provide our patients the most personalized cellular medical care available, we needed to demonstrate that the surgery we practice is first and foremost safe. We continue to make many advances in our investigational work, aggregating patient data and outcomes network-wide, consistently advancing cellular medicine along the way.
